D. Aarsland, K. Andersen, J. Larsen, A. Lolk, and P. Kragh-sørensen, Prevalence and Characteristics of Dementia in Parkinson Disease, Archives of Neurology, vol.60, issue.3, pp.387-92, 2003.
DOI : 10.1001/archneur.60.3.387

A. Abbott, Levodopa: the story so far, Nature, vol.466, issue.7310, pp.6-7, 2010.
DOI : 10.1038/466S6a

I. Arnulf, E. Konofal, M. Merino-andreu, J. Houeto, V. Mesnage et al., Parkinson's disease and sleepiness: An integral part of PD, Neurology, vol.58, issue.7, pp.1019-1043, 2002.
DOI : 10.1212/WNL.58.7.1019

M. Auyeung, T. Tsoi, V. Mok, C. Cheung, C. Lee et al., Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients, Journal of Neurology, Neurosurgery & Psychiatry, vol.83, issue.6, pp.607-618
DOI : 10.1136/jnnp-2011-301590

J. Azulay, F. Durif, R. Rogez, C. Tranchant, I. Bourdeix et al., ??tude Pr??coce??: ??valuation d???un autoquestionnaire de d??pistage et prise en charge pr??coces des fluctuations dans la maladie de Parkinson, Revue Neurologique, vol.164, issue.4, pp.354-62, 2008.
DOI : 10.1016/j.neurol.2008.01.003

P. Baruch, E. Pourcher, and R. Jouvent, PARKINSON??S DISEASE AND MOOD COMPONENTS, Clinical Neuropharmacology, vol.15, p.8, 1992.
DOI : 10.1097/00002826-199202001-00016

P. Barone, A. Antonini, C. Colosimo, R. Marconi, L. Morgante et al., Dotto PD; PRIAMO study group. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord, pp.1641-1650, 2009.

A. Beiske, J. Loge, A. Rønningen, and E. Svensson, Pain in Parkinson???s disease: Prevalence and characteristics, Pain, vol.141, issue.1, pp.173-180, 2009.
DOI : 10.1016/j.pain.2008.12.004

V. Ben and B. Bruguerolle, Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat, Life Sciences, vol.67, issue.13, pp.1549-58, 2000.
DOI : 10.1016/S0024-3205(00)00751-7

A. Benabid, P. Pollak, C. Gross, D. Hoffmann, A. Benazzouz et al., Acute and Long-Term Effects of Subthalamic Nucleus Stimulation in Parkinson's Disease, Stereotactic and Functional Neurosurgery, vol.62, issue.1-4, pp.1-476, 1994.
DOI : 10.1159/000098600

A. Benabid, P. Pollak, A. Louveau, S. Henry, and J. De-rougemont, Combined (Thalamotomy and Stimulation) Stereotactic Surgery of the VIM Thalamic Nucleus for Bilateral Parkinson Disease, Stereotactic and Functional Neurosurgery, vol.50, issue.1-6, pp.1-6344, 1987.
DOI : 10.1159/000100803

A. Benazzouz, C. Gross, J. Féger, T. Boraud, and B. Bioulac, Reversal of Rigidity and Improvement in Motor Performance by Subthalamic High-frequency Stimulation in MPTP-treated Monkeys, European Journal of Neuroscience, vol.21, issue.Suppl. 1, pp.382-391, 1993.
DOI : 10.1111/j.1460-9568.1993.tb00505.x

R. Benca, W. Obermeyer, R. Thisted, and J. Gillin, Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry, 1992.

A. Bonnet, M. Jutras, V. Czernecki, J. Corvol, and M. Vidailhet, Nonmotor Symptoms in Parkinson???s Disease in 2012: Relevant Clinical Aspects, Parkinson's Disease, vol.27, issue.2
DOI : 10.1212/WNL.0b013e3181d55f24

URL : http://doi.org/10.1155/2012/198316

R. Bordet, D. Devos, S. Brique, Y. Touitou, J. Guieu et al., Study of Circadian Melatonin Secretion Pattern at Different Stages of Parkinson's Disease, Clinical Neuropharmacology, vol.26, issue.2, pp.65-72, 2003.
DOI : 10.1097/00002826-200303000-00005

D. Borsook, Neurological diseases and pain, Brain, vol.135, issue.2, pp.320-364, 2011.
DOI : 10.1093/brain/awr271

URL : http://doi.org/10.1093/brain/awr271

A. Boulamery, N. Simon, J. Vidal, and B. Bruguerolle, EFFECTS OF L-DOPA ON CIRCADIAN RHYTHMS OF 6-OHDA STRIATAL LESIONED RATS: A RADIOTELEMETRIC STUDY, Chronobiology International, vol.29, issue.2, pp.251-64, 2010.
DOI : 10.1080/07420520802544530

H. Braak, D. Tredici, K. Rüb, U. De-vos, R. et al., Staging of brain pathology related to sporadic Parkinson???s disease, Neurobiology of Aging, vol.24, issue.2, pp.197-211, 2003.
DOI : 10.1016/S0197-4580(02)00065-9

D. Brandstädter and W. Oertel, Depression in Parkinson's disease, Adv Neurol, vol.91, pp.371-81, 2003.

P. Calabresi, D. Filippo, M. Ghiglieri, V. Tambasco, N. Picconi et al., Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap, The Lancet Neurology, vol.9, issue.11, pp.1106-1123, 2010.
DOI : 10.1016/S1474-4422(10)70218-0

T. Castañeda, B. De-prado, D. Prieto, and F. Mora, Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light, Journal of Pineal Research, vol.49, issue.3, pp.177-85, 2004.
DOI : 10.1046/j.1600-079X.2003.00114.x

P. Chang, D. Ford, L. Mead, L. Cooper-patrick, and M. Klag, Insomnia in Young Men and Subsequent Depression: The Johns Hopkins Precursors Study, American Journal of Epidemiology, vol.146, issue.2, pp.105-119, 1997.
DOI : 10.1093/oxfordjournals.aje.a009241

K. Chaudhuri and A. Schapira, Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment, The Lancet Neurology, vol.8, issue.5, pp.464-74, 2009.
DOI : 10.1016/S1474-4422(09)70068-7

K. Chaudhuri, D. Healy, and A. Schapira, Non-motor symptoms of Parkinson's disease: diagnosis and management, The Lancet Neurology, vol.5, issue.3, pp.235-280, 2006.
DOI : 10.1016/S1474-4422(06)70373-8

S. Cheon, M. Park, W. Kim, and J. Kim, Non-Motor Off Symptoms in Parkinson's Disease, Journal of Korean Medical Science, vol.24, issue.2, pp.311-315, 2009.
DOI : 10.3346/jkms.2009.24.2.311

URL : http://doi.org/10.3346/jkms.2009.24.2.311

C. Comella, T. Nardine, N. Diederich, and G. Stebbins, Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease, Neurology, vol.51, issue.2, pp.526-535, 1998.
DOI : 10.1212/WNL.51.2.526

G. Cotzias, P. Papavasiliou, and R. Gellene, Modification of Parkinsonism—chronic treatment with L-dopa, N Engl J Med Feb, vol.13280, issue.7, pp.337-382, 1969.
DOI : 10.1097/00043764-196912000-00037

P. Critchley, G. Malcolm, P. Malcolm, W. Gibb, J. Arendt et al., Fatigue and melatonin in Parkinson's disease., Journal of Neurology, Neurosurgery & Psychiatry, vol.54, issue.1, pp.91-93, 1991.
DOI : 10.1136/jnnp.54.1.91

J. Cummings, Depression and Parkinson's disease: a review, Am J Psychiatry, vol.149, issue.4, pp.443-54, 1992.

P. Damier, E. Hirsch, Y. Agid, and A. Graybiel, The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease, Brain, vol.122, issue.8, pp.1437-1485, 1999.
DOI : 10.1093/brain/122.8.1437

L. De-lau and M. Breteler, Epidemiology of Parkinson's disease, The Lancet Neurology, vol.5, issue.6, pp.525-560, 2006.
DOI : 10.1016/S1474-4422(06)70471-9

N. Diederich, M. Vaillant, M. Leischen, G. Mancuso, S. Golinval et al., Sleep apnea syndrome in Parkinson's disease. A case-control study in 49 patients, Movement Disorders, vol.5, issue.11, pp.1413-1421, 2005.
DOI : 10.1002/mds.20624

N. Diederich, C. Goetz, and G. Stebbins, Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model, Movement Disorders, vol.54, issue.2, pp.130-170, 2005.
DOI : 10.1002/mds.20308

W. Duncan and . Jr, Circadian rhythms and the pharmacology of affective illness, Pharmacology & Therapeutics, vol.71, issue.3, pp.253-312, 1996.
DOI : 10.1016/S0163-7258(96)00092-7

M. Emre, Dementia associated with Parkinson's disease, The Lancet Neurology, vol.2, issue.4, pp.229-266, 2003.
DOI : 10.1016/S1474-4422(03)00351-X

A. Evans and A. Lees, Dopamine dysregulation syndrome in Parkinson??s disease, Current Opinion in Neurology, vol.17, issue.4, pp.393-401, 2004.
DOI : 10.1097/01.wco.0000137528.23126.41

S. Fahn, D. Oakes, I. Shoulson, K. Kieburtz, A. Rudolph et al., Levodopa and the progression of Parkinson's disease, N Engl J Med, vol.351, issue.24, pp.2498-508, 2004.

F. Francaise-de-neurologie, [Recommendations of the jury on diagnosis and treatment of Parkinson disease. Long text], Rev Neurol, vol.156, issue.2, pp.281-94, 2000.

J. Ferreira, M. Galitzky, J. Montastruc, and O. Rascol, Sleep attacks and Parkinson's disease treatment, The Lancet, vol.355, issue.9212, pp.1333-1337, 2000.
DOI : 10.1016/S0140-6736(00)02119-X

E. Fertl, E. Auff, A. Doppelbauer, and F. Waldhauser, Circadian secretion pattern of melatonin in de novo Parkinsonian patients: evidence for phase-shifting properties of l-dopa, Journal of Neural Transmission - Parkinson's Disease and Dementia Section, vol.i, issue.3, pp.227-261, 1993.
DOI : 10.1007/BF02257677

E. Fertl, E. Auff, A. Doppelbauer, and F. Waldhauser, Circadian secretion pattern of melatonin in Parkinson's disease, Journal of Neural Transmission - Parkinson's Disease and Dementia Section, vol.13, issue.3, pp.41-48, 1991.
DOI : 10.1007/BF02251135

B. Ford, Pain in Parkinson's disease, Clin Neurosci, vol.5, issue.2, pp.63-72, 1998.

R. Fronczek, S. Overeem, S. Lee, I. Hegeman, J. Van-pelt et al., Hypocretin (orexin) loss in Parkinson's disease. Brain, pp.1577-85, 2007.

G. Fénelon, T. Soulas, F. Zenasni, C. De-langavant, and L. , The changing face of Parkinson's disease-associated psychosis: A cross-sectional study based on the new NINDS-NIMH criteria, Movement Disorders, vol.8, issue.suppl 4, pp.763-769, 2010.
DOI : 10.1002/mds.22839

G. Fénelon, C. Goetz, and A. Karenberg, Hallucinations in Parkinson disease in the prelevodopa era, Neurology, vol.66, issue.1, pp.93-101, 2006.
DOI : 10.1212/01.wnl.0000191325.31068.c4

D. Gallagher, A. Lees, and A. Schrag, What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord, Nov, vol.1525, issue.15, pp.2493-500, 2010.

G. Giovannoni, O. Sullivan, J. Turner, K. Manson, A. Lees et al., Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies, Journal of Neurology, Neurosurgery & Psychiatry, vol.68, issue.4, pp.423-431, 2000.
DOI : 10.1136/jnnp.68.4.423

P. Hartikainen, H. Soininen, K. Reinikainen, J. Sirviö, R. Soikkeli et al., Neurotransmitter markers in the cerebrospinal fluid of normal subjects effects of aging and other confounding factors, Journal of Neural Transmission, vol.2, issue.1-2, pp.103-120, 1991.
DOI : 10.1007/BF01249114

M. Hillen and J. Sage, Nonmotor fluctuations in patients with Parkinson's disease, Neurology, vol.47, issue.5, pp.1180-1183, 1996.
DOI : 10.1212/WNL.47.5.1180

T. Hughes, H. Ross, S. Musa, S. Bhattacherjee, R. Nathan et al., A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease, Neurology, vol.54, issue.8, pp.1596-602, 2000.
DOI : 10.1212/WNL.54.8.1596

B. Högl, I. Arnulf, C. Comella, J. Ferreira, A. Iranzo et al., Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord, pp.2704-2720, 2010.

I. Janszky and R. Ljung, Shifts to and from Daylight Saving Time and Incidence of Myocardial Infarction, New England Journal of Medicine, vol.359, issue.18, pp.1966-1974, 2008.
DOI : 10.1056/NEJMc0807104

K. Jellinger, Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts, Movement Disorders, vol.92, issue.Suppl 3, p.22081500, 2011.
DOI : 10.1002/mds.23795

K. Jellinger, Pathology of Parkinson???s disease, Molecular and Chemical Neuropathology, vol.24, issue.Suppl., pp.55-72, 2001.
DOI : 10.1007/BF03159935

T. Kantermann, M. Juda, M. Merrow, and T. Roenneberg, The Human Circadian Clock's Seasonal Adjustment Is Disrupted by Daylight Saving Time, Current Biology, vol.17, issue.22
DOI : 10.1016/j.cub.2007.10.025

G. Kleiner-fisman, J. Herzog, D. Fisman, F. Tamma, K. Lyons et al., Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes, Movement Disorders, vol.70, issue.S14, pp.290-304, 2006.
DOI : 10.1002/mds.20962

P. Krack, A. Batir, N. Van-blercom, S. Chabardes, V. Fraix et al., Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease, New England Journal of Medicine, vol.349, issue.20, pp.1925-1959, 2003.
DOI : 10.1056/NEJMoa035275

G. Krugler, Les premières heures de l’occupation », Revue historique des armées, 1918.

S. Kumar, M. Bhatia, and M. Behari, Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS) Sleep Med, pp.339-381, 2003.
DOI : 10.1016/s1389-9457(03)00105-9

T. Lahti, J. Haukka, J. Lönnqvist, and T. Partonen, Daylight saving time transitions and hospital treatments due to accidents or manic episodes, BMC Public Health, vol.43, issue.3, pp.74-18302734, 2008.
DOI : 10.1053/comp.2002.29849

URL : http://doi.org/10.1186/1471-2458-8-74

T. Lahti, S. Leppämäki, J. Lönnqvist, and T. Partonen, Transitions into and out of daylight saving time compromise sleep and the rest-activity cycles, BMC Physiology, vol.8, issue.1, pp.18269740-2259373, 2008.
DOI : 10.1186/1472-6793-8-3

T. Lahti, S. Leppämäki, J. Lönnqvist, and T. Partonen, Transition to daylight saving time reduces sleep duration plus sleep efficiency of the deprived sleep, Neuroscience Letters, vol.406, issue.3, pp.174-181, 2006.
DOI : 10.1016/j.neulet.2006.07.024

D. Lajugie, N. Bertin, and M. Chantelou, Prévalence de la maladie de Parkinson et coût pour l’Assurance maladie en 2000 en France métropolitaine, Rev Med Ass Maladie, vol.2, pp.113-135, 2005.

S. Lal, I. Isaac, C. Pilapil, N. Nair, N. Hariharasubramanian et al., Effect of apomorphine on melatonin secretion in normal subjects, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.11, issue.2-3, pp.229-262, 1987.
DOI : 10.1016/0278-5846(87)90065-0

J. Langston, P. Ballard, J. Tetrud, and I. Irwin, Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis, Science, vol.219, issue.4587, 1983.
DOI : 10.1126/science.6823561

J. Langston and L. Forno, The hypothalamus in parkinson disease, Annals of Neurology, vol.1, issue.2, pp.129-162, 1978.
DOI : 10.1002/ana.410030207

P. Martinez-martin, M. Jeukens-visser, K. Lyons, C. Rodriguez-blazquez, C. Selai et al., Health-related quality-of-life scales in Parkinson's disease: Critique and recommendations, Movement Disorders, vol.12, issue.Suppl, pp.2371-80, 2011.
DOI : 10.1002/mds.23834

P. Martinez-martin, C. Rodriguez-blazquez, M. Kurtis, K. Chaudhuri, . Nmss-validation et al., The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord, Feb, vol.1526, issue.3, pp.399-406, 2011.

M. Menza, R. Dobkin, H. Marin, and K. Bienfait, Sleep disturbances in Parkinson's disease, Movement Disorders, vol.44, issue.Suppl 1, pp.117-139, 2010.
DOI : 10.1002/mds.22788

T. Monk and S. Folkard, Adjusting to the changes to and from Daylight Saving Time, Nature, vol.261, issue.5562, pp.688-697, 1976.
DOI : 10.1038/261688a0

P. Monteleone and M. Maj, The circadian basis of mood disorders: Recent developments and treatment implications, European Neuropsychopharmacology, vol.18, issue.10, pp.701-712, 2008.
DOI : 10.1016/j.euroneuro.2008.06.007

C. Moreau, S. Cantiniaux, A. Delval, L. Defebvre, and J. Azulay, Les troubles de la marche dans la maladie de Parkinson??: probl??matique clinique et physiopathologique, Revue Neurologique, vol.166, issue.2, pp.158-67, 2009.
DOI : 10.1016/j.neurol.2009.05.010

R. Nussbaum and C. Ellis, Alzheimer's disease and Parkinson's disease, N Engl J Med Review. Erratum N Engl J Med, vol.348348, issue.1425, pp.1356-642588, 2003.

L. Nègre-pagès, W. Regragui, D. Bouhassira, H. Grandjean, and O. Rascol, DoPaMiP Study Group Chronic pain in Parkinson's disease: the crosssectional French DoPaMiP survey, Mov Disord Jul, vol.3023, issue.10, pp.1361-1370, 2008.

O. Sullivan, S. Williams, D. Gallagher, D. Massey, L. Silveira-moriyama et al., Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study, Movement Disorders, vol.21, issue.1, pp.101-107, 2008.
DOI : 10.1002/mds.21813

C. Olanow, J. Obeso, and F. Stocchi, Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications, The Lancet Neurology, vol.5, issue.8, pp.677-87, 2006.
DOI : 10.1016/S1474-4422(06)70521-X

T. Parsons, S. Rogers, A. Braaten, S. Woods, and A. Tröster, Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis, The Lancet Neurology, vol.5, issue.7, pp.578-88, 2006.
DOI : 10.1016/S1474-4422(06)70475-6

R. Postuma, A. Lang, J. Gagnon, A. Pelletier, and J. Montplaisir, How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder, Brain, vol.135, issue.6, pp.1860-70, 2012.
DOI : 10.1093/brain/aws093

URL : http://doi.org/10.1093/brain/aws093

R. Postuma, T. Arenovich, and A. Lang, Does severity of Parkinson's disease vary according to season? Mov Disord, pp.476-485, 2005.

H. Pouclet, T. Lebouvier, M. Flamant, E. Coron, M. Neunlist et al., Autonomic nervous system as a source of biomarkers in Parkinson's disease], Presse Med, pp.695-701, 2012.

H. Pouclet, T. Lebouvier, E. Coron, S. Varannes, T. Rouaud et al., A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease, Neurobiology of Disease, vol.45, issue.1, pp.305-314, 2011.
DOI : 10.1016/j.nbd.2011.08.014

R. Reiter, S. Rosales-corral, A. Coto-montes, J. Boga, D. Tan et al., The photoperiod, circadian regulation and chronodisruption: the requisite interplay between the suprachiasmatic nuclei and the pineal and gut melatonin, J Physiol Pharmacol, vol.62, issue.3, pp.269-74, 2011.

D. Riley and A. Lang, The spectrum of levodopa-related fluctuations in Parkinson's disease, Neurology, vol.43, issue.8, pp.1459-64, 1993.
DOI : 10.1212/WNL.43.8.1459

A. Samii, J. Nutt, and B. Ransom, Parkinson's disease. Lancet, pp.1783-93, 2004.

J. Santamaria, How to evaluate excessive daytime sleepiness in Parkinson's disease. Neurology, pp.21-24, 2004.
DOI : 10.1212/wnl.63.8_suppl_3.s21

A. Schrag, P. Barone, R. Brown, A. Leentjens, W. Mcdonald et al., Depression rating scales in Parkinson's disease: Critique and recommendations, Movement Disorders, vol.51, issue.Pt 4, pp.1077-92, 2007.
DOI : 10.1002/mds.21333

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040268

C. Shapiro, F. Blake, E. Fossey, and B. Adams, Daylight saving time in psychiatric illness, Journal of Affective Disorders, vol.19, issue.3, pp.177-81, 1990.
DOI : 10.1016/0165-0327(90)90089-Q

L. Shulman, R. Taback, J. Bean, and W. Weiner, Comorbidity of the nonmotor symptoms of Parkinson's disease, Movement Disorders, vol.1, issue.3, 2001.
DOI : 10.1002/mds.1099

J. Siegfried and B. Lippitz, Bilateral Chronic Electrostimulation of Ventroposterolateral Pallidum, Neurosurgery, vol.35, issue.6, pp.1126-1135, 1994.
DOI : 10.1227/00006123-199412000-00016

H. Smeding, J. Speelman, M. Koning-haanstra, P. Schuurman, P. Nijssen et al., Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled study, Neurology, vol.66, issue.12, pp.1830-1836, 2006.
DOI : 10.1212/01.wnl.0000234881.77830.66

E. Souetre, E. Salvati, T. Wehr, D. Sack, B. Krebs et al., Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects, Am J Psychiatry, vol.145, issue.9, pp.1133-1140, 1988.

M. Stacy, A. Bowron, M. Guttman, R. Hauser, K. Hughes et al., Identification of motor and nonmotor wearing-off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment, Movement Disorders, vol.18, issue.6, 2005.
DOI : 10.1002/mds.20383

S. Starkstein, Apathy and Parkinson???s Disease, Current Treatment Options in Neurology, vol.75, issue.3, p.22237755, 2012.
DOI : 10.1007/s11940-011-0118-9

T. Thannickal, Y. Lai, and J. Siegel, Hypocretin (orexin) cell loss in Parkinson's disease. Brain, pp.1586-95, 2007.

S. Thobois, C. Ardouin, E. Schmitt, E. Lhommée, H. Klinger et al., Maladie de Parkinson??: de la physiopathologie des troubles psychiques ?? la ma??trise du traitement dopaminergique, Revue Neurologique, vol.166, issue.10, pp.816-837, 2010.
DOI : 10.1016/j.neurol.2010.07.006

E. Tolosa, M. Martí, F. Valldeoriola, and J. Molinuevo, History of levodopa and dopamine agonists in Parkinson's disease treatment, Neurology, vol.50, issue.Issue 6, Supplement 6, 1998.
DOI : 10.1212/WNL.50.6_Suppl_6.S2

E. Van-cauter, R. Leproult, and D. Kupfer, Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol, J Clin Endocrinol Metab, vol.81, issue.7, pp.2468-73, 1996.

J. Volkmann, N. Allert, J. Voges, V. Sturm, A. Schnitzler et al., Long-term results of bilateral pallidal stimulation in Parkinson's disease, Annals of Neurology, vol.72, issue.6, pp.871-876, 2004.
DOI : 10.1002/ana.20091

K. Walsh and G. Bennett, Parkinson's disease and anxiety, Postgraduate Medical Journal, vol.77, issue.904, pp.89-93, 2001.
DOI : 10.1136/pmj.77.904.89

D. Weintraub, Dopamine and impulse control disorders in Parkinson's disease, Annals of Neurology, vol.164, issue.suppl 9, pp.93-100, 2008.
DOI : 10.1002/ana.21454

W. Willett, The Waste of daylight, 1907.

G. Willis, Parkinson's Disease as a Neuroendocrine Disorder of Circadian Function: Dopamine-Melatonin Imbalance and the Visual System in the Genesis and Progression of the Degenerative Process, Reviews in the Neurosciences, vol.19, issue.4-5, pp.4-5245, 2008.
DOI : 10.1515/REVNEURO.2008.19.4-5.245

T. Witjas, E. Kaphan, and J. Azulay, Les fluctuations non motrices de la maladie de Parkinson, Revue Neurologique, vol.163, issue.8-9, pp.846-50, 2007.
DOI : 10.1016/S0035-3787(07)91470-8

T. Witjas, E. Kaphan, J. Azulay, O. Blin, M. Ceccaldi et al., Nonmotor fluctuations in Parkinson's disease: Frequent and disabling, Neurology, vol.59, issue.3, pp.408-421, 2002.
DOI : 10.1212/WNL.59.3.408

K. Witt, C. Daniels, J. Reiff, P. Krack, J. Volkmann et al., Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study, The Lancet Neurology, vol.7, issue.7, pp.605-619, 2008.
DOI : 10.1016/S1474-4422(08)70114-5

M. Zibetti, A. Merola, L. Rizzi, V. Ricchi, S. Angrisano et al., Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease. Mov Disord, pp.2327-2361, 2011.